| Description |
1 online resource (xix, 252 pages) : color illustrations |
| Series |
Consensus study report |
|
Consensus study report.
|
| Contents |
1. Introduction -- 2. Lessons Learned from Other Allocation Efforts -- 3. A Framework for Equitable Allocation of COVID-19 Vaccine -- 4. Applying the Framework for Equitable Allocation of COVID-19 Vaccine in Various Scenarios -- 5. Administering and Implementing an Effective and Equitable National COVID-19 Vaccination Program -- 6. Risk Communication and Community Engagement -- 7. Achieving Acceptance of COVID-19 Vaccine -- 8. Ensuring Equity in COVID-19 Vaccine Allocation Globally -- Appendix A: Study Methods -- Appendix B: Committee and Staff Biosketches |
| Summary |
In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies. Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors. Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine |
| Bibliography |
Includes bibliographical references |
| Notes |
This activity was supported by contracts between the National Academy of Sciences and the Centers for Disease Control and Prevention and the National Institutes of Health (HHSN263201800029I). This project has been funded in whole or in part with federal funds from the Office of Science Policy, National Institutes of Health, U.S. Department of Health and Human Services under Contract No. HHSN263201800029I. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project |
|
Description based on online resource; title from PDF title page (ProQuest Ebook Central, viewed March 3, 2021) |
| Subject |
COVID-19 (Disease) -- Prevention
|
|
COVID-19 (Disease) -- Research
|
|
Influenza vaccines.
|
|
COVID-19 Vaccines -- supply & distribution
|
|
COVID-19 -- prevention & control
|
|
Pandemics -- prevention & control
|
|
Health Care Rationing
|
|
Resource Allocation
|
|
Health Equity
|
|
Influenza Vaccines
|
|
COVID-19 (Disease) -- Prevention
|
|
COVID-19 (Disease) -- Research
|
|
Influenza vaccines
|
| SUBJECT |
United States https://id.nlm.nih.gov/mesh/D014481 |
| Form |
Electronic book
|
| Author |
Gayle, Helene D., editor
|
|
Foege, William H., 1936- editor.
|
|
Brown, Lisa (Lisa M.), editor.
|
|
Kahn, Benjamin, editor
|
|
National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, issuing body.
|
|
National Academies of Sciences, Engineering, and Medicine (U.S.). Board on Population Health and Public Health Practice, issuing body.
|
| LC no. |
2020947136 |
| ISBN |
9780309682275 |
|
0309682274 |
|
9780309682251 |
|
0309682258 |
|
